Effects of valdecoxib in the treatment of chronic low back pain: Results of a randomized, placebo-controlled trial

Clinical Therapeutics

Volumn 26, Issue 8, 2004, Pages 1249-1260

  Coats, Teresa L ^a   Borenstein, David G ^b   Nangia, Narinder K ^c   Brown, Mark T ^c  

^a Benchmark Research   (United States)

^b Arthritis and Rheumatism Associates   (United States)

^c PFIZER INC   (United States)

Author keywords

analgesia; COX 2 inhibition; low back pain; valdecoxib

Indexed keywords

CYCLOOXYGENASE 2 INHIBITOR; PLACEBO; VALDECOXIB; ISOXAZOLE DERIVATIVE; PROSTAGLANDIN SYNTHASE INHIBITOR; SULFONAMIDE;

ABDOMINAL PAIN; ADULT; AGED; ANALGESIA; ANALGESIC ACTIVITY; ANOREXIA; ARTHRALGIA; ARTICLE; BRONCHITIS; CARDIOVASCULAR DISEASE; CHRONIC PAIN; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DIZZINESS; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG EFFICACY; DRUG TOLERABILITY; DYSPEPSIA; FEMALE; FLATULENCE; HEADACHE; HUMAN; KIDNEY DISEASE; LOW BACK PAIN; MALE; MIGRAINE; MULTICENTER STUDY; PAIN; PAIN ASSESSMENT; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME; UPPER RESPIRATORY TRACT INFECTION; CANADA; MIDDLE AGED; PATHOLOGY; PROSPECTIVE STUDY; QUESTIONNAIRE; UNITED STATES;

ADULT; AGED; CANADA; CYCLOOXYGENASE INHIBITORS; DOUBLE-BLIND METHOD; FEMALE; HUMANS; ISOXAZOLES; LOW BACK PAIN; MALE; MIDDLE AGED; PAIN MEASUREMENT; PROSPECTIVE STUDIES; QUESTIONNAIRES; SULFONAMIDES; TREATMENT OUTCOME; UNITED STATES;

EID: 6344221458     PISSN: 01492918     EISSN: 1879114X     Source Type: Journal    
DOI: 10.1016/S0149-2918(04)80081-X     Document Type: Article

References (32)

1. Maetzel A, and Li L The economic burden of low back pain: A review of studies published between 1996 and 2001 Best Pract Res Clin Rheumatol 16 2002 23 30
2. Cherkin DC, Wheeler KJ, Barlow W, and Deyo RA Medication use for low back pain in primary care Spine 23 1998 607 614
3. Frymoyer JW Back pain and sciatica N Engl J Med 318 1988 291 300
4. Deyo RA Drug therapy for back pain Which drugs help which patients? Spine 21 1996 2840 2849
5. Camu F, Beecher T, Recker DP, and Verburg KM Valdecoxib, a COX-2-specific inhibitor, is an efficacious, opioid-sparing analgesic in patients undergoing hip arthroplasty Am J Ther 9 2002 43 51
6. Kehlet H, Rung GW, and Callesen T Postoperative opioid analgesia: Time for a reconsideration? J Clin Anesth 8 1996 441 445
7. van Tulder MW, Scholten RJ, Koes BW, and Deyo RA Nonsteroidal anti-inflammatory drugs for low back pain: A systematic review within the framework of the Cochrane Collaboration Back Review Group Spine 25 2000 2501 2513
8. Borda IT The spectrum of adverse gastrointestinal effects associated with nonsteroidal anti-inflammatory drugs Borda IT Koff RS NSAIDs: A Profile of Adverse Effects 1992 Hanley & Belfus New York 25 81
9. [published correction appears in N Engl J Med. 1991; 325: 747] Brooks PM, and Day RO Nonsteroidal antiinflammatory drugs-differences and similarities N Engl J Med 324 1991 1716 1725
10. Seibert K, Zhang Y, and Leahy K Pharmacological and biochemical demonstration of the role of cyclooxygenase 2 in inflammation and pain Proc Natl Acad Sci USA 91 1994 12013 12017
11. Masferrer JL, Zweifel BS, and Manning PT Selective inhibition of inducible cyclooxygenase 2 in vivo is antiinflammatory and nonulcerogenic Proc Natl Acad Sci USA 91 1994 3228 3232
12. [published correction appears in N Engl J Med. 1999; 341: 548] Wolfe MM, Lichtenstein DR, and Singh G Gastrointestinal toxicity of nonsteroidal antiinflammatory drugs N Engl J Med 340 1999 1888 1899
13. Day R, Morrison B, Luza A for the Rofecoxib/ Ibuprofen Comparator Study Group A randomized trial of the efficacy and tolerability of the COX-2 inhibitor rofecoxib vs ibuprofen in patients with osteoarthritis Arch Intern Med 160 2000 1781 1787
14. Emery P, Zeidler H, and Kvien TK Celecoxib versus diclofenac in long-term management of rheumatoid arthritis: Randomised double-blind comparison Lancet 354 1999 2106 2111
15. Silverstein FE, Faich G, and Goldstein JL Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: The CLASS study: A randomized controlled trial Celecoxib Long-term Arthritis Safety Study JAMA 284 2000 1247 1255
16. Watson DJ, Harper SE, and Zhao PL Gastrointestinal tolerability of the selective cyclooxygenase-2 (COX-2) inhibitor rofecoxib compared with nonselective COX-1 and COX-2 inhibitors in osteoarthritis Arch Intern Med 160 2000 2998 3003
17. Talley JJ, Brown DL, and Carter JS 4-[5-Methyl-3-phenylisoxazol-4-yl]- benzenesulfonamide, valdecoxib: A potent and selective inhibitor of COX-2 J Med Chem 43 2000 775 777
18. Malmstrom K, Daniels S, and Kotey P Comparison of rofecoxib and celecoxib, two cyclooxygenase-2 inhibitors, in postoperative dental pain: A randomized, placebo- and active- comparator-controlled clinical trial Clin Ther 21 1999 1653 1663
19. Desjardins PJ, Shu VS, and Recker DP A single preoperative oral dose of valdecoxib, a new cyclooxygenase-2 specific inhibitor, relieves post-oral surgery or bunionectomy pain Anesthesiology 97 2002 565 573
20. Daniels SE, Desjardins PJ, and Talwalker S The analgesic efficacy of valdecoxib vs. oxycodone/ acetaminophen after oral surgery J Am Dent Assoc 133 2002 611 621
21. Quebec Task Force on Spinal Disorders Scientific approach to the assessment and management of activity-related spinal disorders A monograph for clinicians. Report of the Quebec Task Force on Spinal Disorders Spine 12 7 Suppl 1987 S1 S59
22. Bextra 2003 Pfizer Inc and Pharmacia Philadelphia, Pa
23. Roland M, and Morris R A study of the natural history of back pain. Part I: Development of a reliable and sensitive measure of disability in low-back pain Spine 8 1983 141 144
24. Ehrich EW, Davies GM, and Watson DJ Minimal perceptible clinical improvement with the Western Ontario and McMaster Universities osteoarthritis index questionnaire and global assessments in patients with osteoarthritis J Rheumatol 27 2000 2635 2641
25. Abstract Daniels SE, Talwalker S, and Hubbard RC Pre-operative valdecoxib, a COX-2 specific inhibitor, provides effective and long lasting pain relief following oral surgery Anesthesiology 95 2001 A 810
26. Abstract Desjardins PJ, Talwalker S, and Hubbard RC Pre-operative administration of valdecoxib, a potent COX-2 specific inhibitor, provides effective postoperative analgesia Anesthesiology 95 2001 A 811
27. Abstract F 14 Thomas HM, Le V, and Brown MT Valdecoxib effectively treats a single moderate or severe acute migraine headache Headache 43 2003 523
28. Gallagher EJ, Liebman M, and Bijur PE Prospective validation of clinically important changes in pain severity measured on a visual analog scale Ann Emerg Med 38 2001 633 638
29. Todd KH, Funk KG, Funk JP, and Bonacci R Clinical significance of reported changes in pain severity Ann Emerg Med 27 1996 485 489
30. Schnitzer TJ, Gray WL, Paster RZ, and Kamin M Efficacy of tramadol in treatment of chronic low back pain J Rheumatol 27 2000 772 778
31. Faucett J Chronic low back pain: Early interventions Annu Rev Nurs Res 17 1999 155 182
32. Simmonds MJ, Kumar S, and Lechelt E Psychological factors in disabling low back pain: Causes or consequences? Disabil Rehabil 18 1996 161 168